サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541128

冠動脈ステントの市場レポート：タイプ、生体材料、送達モード、エンドユーザー、地域別、2024年～2032年

Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 135 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.20円
冠動脈ステントの市場レポート：タイプ、生体材料、送達モード、エンドユーザー、地域別、2024年～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の冠動脈ステントの市場規模は2023年に111億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに182億米ドルに達し、2024～2032年の成長率（CAGR）は5.46％になると予測しています。

冠動脈ステントは、バルーン血管形成術の後に狭い冠動脈の開口部を維持するために導入される、自己拡張型の小さな管状の金属製デバイスです。これらのステントは薬剤でコーティングされており、プラークが蓄積して動脈壁が再び狭くなるのを防ぐためにゆっくりと放出されます。また、胸痛や息切れなどの心臓病の症状を緩和し、心臓への血液と酸素の正常な流れを可能にします。冠動脈ステントは低侵襲（MI）であり、回復に要する時間も短いため、冠動脈バイパス手術よりも世界中で支持を集めています。

冠動脈ステントの市場動向：

糖尿病、肥満、高血圧の増加により、動脈硬化疾患のリスクが高まっています。これは、心血管疾患（CVD）を発症する可能性が高い高齢者人口の増加とともに、冠動脈ステント市場の成長を促す重要な要因の一つとなっています。これとは別に、低侵襲手術（MIS）の人気の高まりが、切開創が小さく、入院期間が短く、回復が早い冠動脈ステントの採用を増やしています。その他の市場成長要因としては、分岐型ステントの市場開拓、ヘルスケアインフラの改善、生分解性材料を使用した製品製造の増加などが挙げられます。さらに、大手市場プレーヤーは先進的な製品を投入しており、これが今後数年間の市場を牽引すると予想されます。

本レポートで扱う主な質問

  • 2023年の世界の冠動脈ステントの市場の市場規模は？
  • 2024年から2032年にかけての世界の冠動脈ステントの市場の予想成長率は？
  • 世界の冠動脈ステントの市場を牽引する主要因は何か？
  • 世界の冠動脈ステントの市場に対するCOVID-19の影響は？
  • 世界の冠動脈ステントの市場のタイプ別内訳は？
  • 世界の冠動脈ステントの市場の生体材料別の内訳は？
  • 世界の冠動脈ステントの市場のうち、送達様式に基づく内訳は？
  • 世界の冠動脈ステントの市場のエンドユーザー別の内訳は？
  • 冠動脈ステントの市場の世界における主要地域は？
  • 世界の冠動脈ステントの市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の冠動脈ステント市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 薬剤溶出ステント
    • 市場動向
    • 市場予測
  • ベアメタル冠動脈ステント
    • 市場動向
    • 市場予測
  • 生体吸収性ステント
    • 市場動向
    • 市場予測

第7章 市場内訳：生体材料

  • 金属生体材料
    • 市場動向
    • 市場予測
  • ポリマー生体材料
    • 市場動向
    • 市場予測
  • 天然生体材料
    • 市場動向
    • 市場予測

第8章 市場内訳：送達モード別

  • バルーン拡張型ステント
    • 市場動向
    • 市場予測
  • 自己拡張型ステント
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • Elixir Medical Corporation
    • Lepu Medical Technology（Beijing）Co. Ltd.
    • Medtronic plc
    • Meril Life Sciences Pvt. Ltd.
    • MicroPort Scientific Corporation
    • Terumo Corporation
    • Translumina GmbH
図表

List of Figures

  • Figure 1: Global: Coronary Stents Market: Major Drivers and Challenges
  • Figure 2: Global: Coronary Stents Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Coronary Stents Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Coronary Stents Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Coronary Stents Market: Breakup by Biomaterial (in %), 2023
  • Figure 6: Global: Coronary Stents Market: Breakup by Mode of Delivery (in %), 2023
  • Figure 7: Global: Coronary Stents Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Coronary Stents Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Coronary Stents (Drug-eluting Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Coronary Stents (Drug-eluting Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Coronary Stents (Bare-metal Coronary Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Coronary Stents (Bare-metal Coronary Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Coronary Stents (Bioabsorbable Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Coronary Stents (Bioabsorbable Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Coronary Stents (Metallic Biomaterial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Coronary Stents (Metallic Biomaterial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Coronary Stents (Polymeric Biomaterial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Coronary Stents (Polymeric Biomaterial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Coronary Stents (Natural Biomaterial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Coronary Stents (Natural Biomaterial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Coronary Stents (Balloon-expandable Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Coronary Stents (Balloon-expandable Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Coronary Stents (Self-expanding Stents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Coronary Stents (Self-expanding Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Coronary Stents (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Coronary Stents (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Coronary Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Coronary Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Coronary Stents (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Coronary Stents (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia-Pacific: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia-Pacific: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Coronary Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Coronary Stents Market: Breakup by Country (in %), 2023
  • Figure 79: Middle East and Africa: Coronary Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Global: Coronary Stents Industry: SWOT Analysis
  • Figure 81: Global: Coronary Stents Industry: Value Chain Analysis
  • Figure 82: Global: Coronary Stents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Coronary Stents Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Coronary Stents Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Coronary Stents Market Forecast: Breakup by Biomaterial (in Million US$), 2024-2032
  • Table 4: Global: Coronary Stents Market Forecast: Breakup by Mode of Delivery (in Million US$), 2024-2032
  • Table 5: Global: Coronary Stents Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Coronary Stents Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Coronary Stents Market: Competitive Structure
  • Table 8: Global: Coronary Stents Market: Key Players
目次
Product Code: SR112024A6083

The global coronary stents market size reached US$ 11.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 18.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.46% during 2024-2032.

Coronary stents are small, self-expanding tubular metallic devices introduced inside narrow coronary arteries to keep them open after a balloon angioplasty procedure. These stents are coated with a medication, which is slowly released to prevent the walls of arteries from plaque buildup and re-narrowing. They also alleviate heart disease symptoms, such as chest pain and shortness of breath, and allow normal flow of blood and oxygen to the heart. As they are minimally invasive (MI) and require shorter recovery time, coronary stents are gaining traction over coronary artery bypass surgeries around the world.

Coronary Stents Market Trends:

The growing incidence of diabetes, obesity and high blood pressure (BP) is escalating the risk of atherosclerosis disease. This, along with the rising geriatric population, which is more likely to develop cardiovascular diseases (CVDs), represents one of the significant factors impelling the growth of the coronary stent market. Apart from this, the growing popularity of minimally invasive surgeries (MIS) is resulting in the increasing adoption of coronary stents that involve small incision wounds, short hospital stays and fast recovery. Other factors contributing to the market growth include the development of bifurcated stents, improving healthcare infrastructure and rising manufacturing of products using biodegradable materials. Furthermore, the leading market players are introducing advanced products, which is anticipated to drive the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global coronary stents market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, biomaterial, mode of delivery and end user.

Breakup by Type:

Drug-eluting Stents

Bare-metal Coronary Stents

Bioabsorbable Stents

Breakup by Biomaterial:

Metallic Biomaterial

Polymeric Biomaterial

Natural Biomaterial

Breakup by Mode of Delivery:

Balloon-expandable Stents

Self-expanding Stents

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Terumo Corporation and Translumina GmbH.

Key Questions Answered in This Report

  • 1. What was the size of the global coronary stents market in 2023?
  • 2. What is the expected growth rate of the global coronary stents market during 2024-2032?
  • 3. What are the key factors driving the global coronary stents market?
  • 4. What has been the impact of COVID-19 on the global coronary stents market?
  • 5. What is the breakup of the global coronary stents market based on the type?
  • 6. What is the breakup of the global coronary stents market based on biomaterial?
  • 7. What is the breakup of the global coronary stents market based on the mode of delivery?
  • 8. What is the breakup of the global coronary stents market based on the end user?
  • 9. What are the key regions in the global coronary stents market?
  • 10. Who are the key players/companies in the global coronary stents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Coronary Stents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Drug-eluting Stents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bare-metal Coronary Stents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Bioabsorbable Stents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Biomaterial

  • 7.1 Metallic Biomaterial
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymeric Biomaterial
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Natural Biomaterial
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Mode of Delivery

  • 8.1 Balloon-expandable Stents
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Self-expanding Stents
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 B. Braun Melsungen AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Biotronik SE & Co. KG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 SWOT Analysis
    • 15.3.4 Boston Scientific Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Elixir Medical Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Lepu Medical Technology (Beijing) Co. Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Medtronic plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Meril Life Sciences Pvt. Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 MicroPort Scientific Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Terumo Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Translumina GmbH
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio